Mirum Pharmaceuticals Inc (MIRM)
42.17
+0.44
(+1.05%)
USD |
NASDAQ |
Dec 24, 16:00
Mirum Pharmaceuticals Cash from Investing (Quarterly): -18.04M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 84.78M |
| Cytokinetics Inc | -45.05M |
| Amicus Therapeutics Inc | 34.27M |
| Ocugen Inc | -0.507M |
| Scholar Rock Holding Corp | 35.31M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.984M |
| Cash from Financing (Quarterly) | 3.863M |
| Free Cash Flow | -27.20M |
| Free Cash Flow Per Share (Quarterly) | -0.1297 |
| Free Cash Flow to Equity (Quarterly) | -6.621M |
| Free Cash Flow to Firm (Quarterly) | -6.077M |
| Free Cash Flow Yield | -1.37% |